Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for drug discovery and development ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

AI isn’t a silver bullet for drug discovery. While it can drastically speed up finding the right compounds needed to make new drugs, the most time-consuming steps — like wet lab tests with ...

Five years since it launched, advances powered by the National Drug Discovery Centre are helping transform medical research in Australia and fast-tracking development of new home-grown treatments.

I decided to form Insilico and focus entirely on deep learning for every step of drug discovery and development. We decided not to go small, but to go after a grand goal with a very limited amount ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

Configurable informatics platform improves lab efficiency, data tracking, and resource management from plasmid to structure ...

Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...